tradingkey.logo

QuidelOrtho Corp

QDEL
查看详细走势图
29.865USD
+0.915+3.16%
交易中 美东报价延迟15分钟
2.03B总市值
亏损市盈率 TTM

QuidelOrtho Corp

29.865
+0.915+3.16%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+3.16%

5天

+3.70%

1月

+22.65%

6月

+6.55%

今年开始到现在

-32.96%

1年

-33.40%

查看详细走势图

TradingKey QuidelOrtho Corp股票评分

单位: USD 更新时间: 2025-12-19

操作建议

QuidelOrtho Corp当前公司基本面数据相对谨慎,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名61/208位。机构持股占比非常高,近一月多位分析师给出公司评级为持有。最高目标价36.86。中期看,股价处于平稳状态。近一个月,市场表现很强,技术面评分较高,但很强的走势得没有得到基本面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。

QuidelOrtho Corp评分

相关信息

行业排名
61 / 208
全市场排名
157 / 4582
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 8 位分析师
持有
评级
36.857
目标均价
+35.70%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

QuidelOrtho Corp亮点

亮点风险
QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics and Ortho Optix.
估值合理
公司最新PE估值-1.66,处于3年历史合理位
机构减仓
最新机构持股79.44M股,环比减少22.58%
景顺投资公司持仓
明星投资者景顺投资公司持仓,最新持仓市值245.91K

QuidelOrtho Corp新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

QuidelOrtho Corp简介

QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics and Ortho Optix.
公司代码QDEL
公司QuidelOrtho Corp
CEOBlaser (Brian J)
网址https://www.quidelortho.com/

常见问题

QuidelOrtho Corp(QDEL)的当前股价是多少?

QuidelOrtho Corp(QDEL)的当前股价是 29.865。

QuidelOrtho Corp的股票代码是什么?

QuidelOrtho Corp的股票代码是QDEL。

QuidelOrtho Corp股票的52周最高点是多少?

QuidelOrtho Corp股票的52周最高点是49.450。

QuidelOrtho Corp股票的52周最低点是多少?

QuidelOrtho Corp股票的52周最低点是19.500。

QuidelOrtho Corp的市值是多少?

QuidelOrtho Corp的市值是2.03B。

QuidelOrtho Corp的净利润是多少?

QuidelOrtho Corp的净利润为-2.05B。

现在QuidelOrtho Corp(QDEL)的股票是买入、持有还是卖出?

根据分析师评级,QuidelOrtho Corp(QDEL)的总体评级为持有,目标价格为36.857。

QuidelOrtho Corp(QDEL)股票的每股收益(EPS TTM)是多少

QuidelOrtho Corp(QDEL)股票的每股收益(EPS TTM)是-17.401。
KeyAI